VANGUARD GROUP INC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$4,887,283
-34.6%
2,124,906
+3.7%
0.00%
Q2 2023$7,477,112
+26.7%
2,048,524
+23.9%
0.00%
Q1 2023$5,903,338
+35.5%
1,653,596
+8.2%
0.00%
Q4 2022$4,357,451
+28.3%
1,528,930
+0.4%
0.00%
Q3 2022$3,395,000
-10.4%
1,522,3190.0%0.00%
Q2 2022$3,791,000
-53.0%
1,522,319
-7.9%
0.00%
Q1 2022$8,070,000
-54.0%
1,653,737
+6.6%
0.00%
Q4 2021$17,546,000
-23.5%
1,551,314
-1.4%
0.00%
-100.0%
Q3 2021$22,930,000
+26.4%
1,573,720
+1.0%
0.00%
Q2 2021$18,147,000
-4.3%
1,557,718
+0.2%
0.00%
-100.0%
Q1 2021$18,965,000
+5.0%
1,554,450
+7.6%
0.00%0.0%
Q4 2020$18,070,000
-13.0%
1,444,537
+4.6%
0.00%0.0%
Q3 2020$20,782,000
-36.6%
1,380,916
+3.2%
0.00%0.0%
Q2 2020$32,785,000
+149.1%
1,337,660
+44.3%
0.00%0.0%
Q1 2020$13,159,000
-6.8%
927,287
+4.2%
0.00%
Q4 2019$14,125,000
+121.9%
889,716
+17.8%
0.00%
Q3 2019$6,366,000
+15.7%
755,152
+23.4%
0.00%
Q2 2019$5,504,000
+55.7%
612,151
+33.8%
0.00%
Q1 2019$3,536,000
+155.7%
457,512
+55.5%
0.00%
Q4 2018$1,383,000
-76.9%
294,272
-55.5%
0.00%
Q3 2018$5,987,000
-24.5%
661,616
-1.0%
0.00%
Q2 2018$7,926,000
+24.8%
668,339
+47.9%
0.00%
Q1 2018$6,349,000451,8630.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bleichroeder LP 755,028$1,736,5640.43%
Monaco Asset Management SAM 359,739$827,4000.24%
Slate Path Capital LP 2,402,455$5,525,6470.15%
SANDERS MORRIS HARRIS LLC 346,212$713,4260.15%
ADVISORY RESEARCH INC 257,225$591,6180.08%
Robertson Stephens Wealth Management, LLC 478,500$1,100,5500.07%
Annandale Capital, LLC 65,000$1500.04%
Good Life Advisors, LLC 112,000$257,6000.03%
CARLSON CAPITAL L P 135,000$310,5000.02%
CORNERCAP INVESTMENT COUNSEL INC 57,888$133,1420.02%
View complete list of CUE BIOPHARMA INC shareholders